Latest News and Press Releases

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course...

MicrobiotiX and WAFCIRC sign MoU and Research Collaboration Agreement in Ghana, launching clinical research to evaluate phage therapy for AMR infections.

Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "Global Biotech Handbook" directory has been added to ResearchAndMarkets.com's offering. The fully revised and expanded Global Biotech Handbook...

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel,...

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel,...

The acquisition expands scalable trial operations across real-world care settings

Le venglustat de Sanofi a atteint tous les critères d'évaluation principaux dans une étude de phase 3 sur la maladie de Gaucher de type 3 Dans l’étude de phase 3 LEAP2MONO, le venglustat, administré...

Sanofi's investigational drug venglustat improved the neurologic symptoms of type 3 Gaucher disease, for which there are currently no approved therapies.

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "GCP (Good Clinical Practice) and Clinical Research Update - Hot Inspection Topics Training Course (May 19, 2026)" training has been added to ...

Kelly McKee to help shape Science 37’s future patient experience, driving growth through modernized trials, innovation, and cross-team collaboration.